Clinical Trial

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Recruiting
View on ClinicalTrials.gov →
Summary
The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone. A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone. The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-23; most recent amendment 2026-05-27.
Status change: Not Yet Recruiting → Recruiting 2025-12-02
Trial Details
NCT Number NCT07201194
Lead Sponsor Vejle Hospital
Conditions Breast Cancer, Prostate Cancer, Lung Cancer, Gynaecologic Cancer, Colorectal Cancer, Pancreatic Cancer Metastatic
Enrollment 90 participants
Start Date 2025-11-17
Primary Completion 2027-04 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-28